Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor
Haig Aghajanian(Therapeutics Clinical Research), Jonathan A. Epstein(California Institute for Regenerative Medicine), Vivienne C. Ho(California Institute for Regenerative Medicine), Madison R. Herling(University of Pennsylvania), Eldad Tzahor(Weizmann Institute of Science), Lauren J. Manderfield(University of Pennsylvania), Li Li(University of Pennsylvania), Mudit Gupta(University of Pennsylvania), Young Kuk Cho(Chonnam National University), Karl Degenhardt(Children's Hospital of Philadelphia), Alla Aharonov(Weizmann Institute of Science)
Cited by 40
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|792
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force
|Genetics in Medicine|2002|398
Plasticity of Hopx+ type I alveolar cells to regenerate type II cells in the lung
|Nature Communications|2015|309
Immune Cells and Immunotherapy for Cardiac Injury and Repair
|Circulation Research|2021|267